From X-ray crystallographic structure to intrinsic thermodynamics of protein-ligand binding using carbonic anhydrase isozymes as a model system

被引:2
作者
Paketuryte-Latve, Vaida [1 ]
Smirnov, Alexey [1 ]
Manakova, Elena [2 ]
Baranauskiene, Lina [1 ]
Petrauskas, Vytautas [1 ]
Zubriene, Asta [1 ]
Matuliene, Jurgita [1 ]
Dudutiene, Virginija [1 ]
Capkauskaite, Edita [1 ]
Zaksauskas, Audrius [1 ]
Leitans, Janis
Grazulis, Saulius [4 ]
Tars, Kaspars [3 ]
Matulis, Daumantas [1 ]
机构
[1] Vilnius Univ, Inst Biotechnol, Dept Biothermodynam & Drug Design, Life Sci Ctr, Sauletekio 7, LT-10257 Vilnius, Lithuania
[2] Vilnius Univ, Inst Biotechnol, Dept Prot DNA Interact, Life Sci Ctr, Sauletekio 7, LT-10257 Vilnius, Lithuania
[3] Latvian Biomed Res & Study Ctr, Ratsupites 1 k-1, LV-1067 Riga, Latvia
[4] Vilnius Univ, Inst Biotechnol, Sect Crystall & Chem Informat, Life Sci Ctr, Sauletekio 7, LT-10257 Vilnius, Lithuania
来源
IUCRJ | 2024年 / 11卷
关键词
drug discovery; protein structure; molecular recognition; X-ray crystallography; intermolecular interactions; carbonic anhydrase isozymes; protein-ligand binding; intrinsic thermodynamics; binding assays; ISOTHERMAL TITRATION CALORIMETRY; INHIBITORS; EXPRESSION; AFFINITY; CRYSTALLIZATION; ASSOCIATION; STABILITY; TRANSPORT; CONSTANT; FEATURES;
D O I
10.1107/S2052252524004627
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Carbonic anhydrase (CA) was among the first proteins whose X-ray crystal structure was solved to atomic resolution. CA proteins have essentially the same fold and similar active centers that differ in only several amino acids. Primary sulfonamides are well defined, strong and specific binders of CA. However, minor variations in chemical structure can significantly alter their binding properties. Over 1000 sulfonamides have been designed, synthesized and evaluated to understand the correlations between the structure and thermodynamics of their binding to the human CA isozyme family. Compound binding was determined by several binding assays: fluorescence-based thermal shift assay, stopped-flow enzyme activity inhibition assay, isothermal titration calorimetry and competition assay for enzyme expressed on cancer cell surfaces. All assays have advantages and limitations but are necessary for deeper characterization of these protein-ligand interactions. Here, the concept and importance of intrinsic binding thermodynamics is emphasized and the role of structure-thermodynamics correlations for the novel inhibitors of CA IX is discussed - an isozyme that is overexpressed in solid hypoxic tumors, and thus these inhibitors may serve as anticancer drugs. The abundant structural and thermodynamic data are assembled into the Protein-Ligand Binding Database to understand general protein-ligand recognition principles that could be used in drug discovery.
引用
收藏
页码:556 / 569
页数:14
相关论文
共 76 条
  • [1] The CCP4 suite: integrative software for macromolecular crystallography
    Agirre, Jon
    Atanasova, Mihaela
    Bagdonas, Haroldas
    Ballard, Charles B.
    Basle, Arnaud
    Beilsten-Edmands, James
    Borges, Rafael J.
    Brown, David G.
    Burgos-Marmol, J. Javier
    Berrisford, John M.
    Bond, Paul S.
    Caballero, Iracema
    Catapano, Lucrezia
    Chojnowski, Grzegorz
    Cook, Atlanta G.
    Cowtan, Kevin D.
    Croll, Tristan I.
    Debreczeni, Judit E.
    Devenish, Nicholas E.
    Dodson, Eleanor J.
    Drevon, Tarik R.
    Emsley, Paul
    Evans, Gwyndaf
    Evans, Phil R.
    Fando, Maria
    Foadi, James
    Fuentes-Montero, Luis
    Garman, Elspeth F.
    Gerstel, Markus
    Gildea, Richard J.
    Hatti, Kaushik
    Hekkelman, Maarten L.
    Heuser, Philipp
    Hoh, Soon Wen
    Hough, Michael A.
    Jenkins, Huw T.
    Jimenez, Elisabet
    Joosten, Robbie P.
    Keegan, Ronan M.
    Keep, Nicholas
    Krissinel, Eugene B.
    Kolenko, Petr
    Kovalevskiy, Oleg
    Lamzin, Victor S.
    Lawson, David M.
    Lebedev, Andrey A.
    Leslie, Andrew G. W.
    Lohkamp, Bernhard
    Long, Fei
    Maly, Martin
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2023, 79 : 449 - 461
  • [2] Bicarbonate Transport in Health and Disease
    Alka, Kumari
    Casey, Joseph R.
    [J]. IUBMB LIFE, 2014, 66 (09) : 596 - 615
  • [3] Bahr G., 2023, Compr. Inorg. Chem., VIII, P231
  • [4] Baranauskiene L., 2019, Carbonic anhydrase as drug target, P39, DOI [DOI 10.1007/978-3-030-12780-03, 10.1007/978-3-030-12780-03, DOI 10.1007/978-3-030-12780-0_3]
  • [5] Inhibition and binding studies of carbonic anhydrase isozymes I, II and IX with benzimidazo[1,2-c][1,2,3]-thiadiazole-7-sulphonamides
    Baranauskiene, Lina
    Hilvo, Mika
    Matuliene, Jurgita
    Golovenko, Dmitrij
    Manakova, Elena
    Dudutiene, Virginija
    Michailoviene, Vilma
    Torresan, Jolanta
    Jachno, Jelena
    Parkkila, Seppo
    Maresca, Alfonso
    Supuran, Claudiu T.
    Grazulis, Saulius
    Matulis, Daumantas
    [J]. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2010, 25 (06) : 863 - 870
  • [6] Titration Calorimetry Standards and the Precision of Isothermal Titration Calorimetry Data
    Baranauskiene, Lina
    Petrikaite, Vilma
    Matuliene, Jurgita
    Matulis, Daumantas
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2009, 10 (06) : 2752 - 2762
  • [7] Carbonic anhydrase IX and acid transport in cancer
    Becker, Holger M.
    [J]. BRITISH JOURNAL OF CANCER, 2020, 122 (02) : 157 - 167
  • [8] Calorimetric investigation of proton linkage by monitoring both the enthalpy and association constant of binding: Application to the interaction of the Src SH2 domain with a high-affinity tyrosyl phosphopeptide
    Bradshaw, JM
    Waksman, G
    [J]. BIOCHEMISTRY, 1998, 37 (44) : 15400 - 15407
  • [9] Why bicarbonate?
    Casey, Joseph R.
    [J]. BIOCHEMISTRY AND CELL BIOLOGY, 2006, 84 (06) : 930 - 939
  • [10] Carbonic Anhydrase Inhibitors and Epilepsy: State of the Art and Future Perspectives
    Ciccone, Lidia
    Cerri, Chiara
    Nencetti, Susanna
    Orlandini, Elisabetta
    [J]. MOLECULES, 2021, 26 (21):